Back

External validation of the biomarker based ABCD score in atrial fibrillation patients with a non gender CHA2DS2 VASc score 0 to 1, A Korean multicenter retrospective cohort

28 August 2022 (12:15 - 12:45)
Organised by:
Congress Presentation Part of: How to prevent best prevent stroke in atrial fibrillation patients Stroke in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Moonki Jung

Chung-Ang University, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Thromboembolic risk dynamics, integrated care management and outcomes in patients with atrial fibrillation: a proof-of-concept analysis from the SPORTIF trials
Doctor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Longitudinal changes in CHA2DS2-VASc and HAS-BLED scores are superior to baseline score values for predicting ischemic stroke and major bleeding in atrial fibrillation patients
Doctor J. Rivera-Caravaca (Murcia, ES)
Abstract Slides
Presentation thumbnail
The impact of mitral regurgitation on the incidence of stroke in patients with atrial fibrillation
Assistant Professor M. Hieda (Fukuoka, JP)
Abstract Slides
Presentation thumbnail
Usefulness of echocardiographic parameters in predicting the incidence of ischemic stroke in japanese patients with non-valvular atrial fibrillation.
Doctor Y. Tezuka (Kyoto, JP) Doctor M. Akao (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: impact of atrial fibrillation
Mr M. Alobaida (Riyadh, SA)
Abstract Slides

Access the full session

Session thumbnail
How to prevent best prevent stroke in atrial fibrillation patients

The Event

Event poster

ESC Congress 2022

28 August 2022 12:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources